About the Authors
- Cristina Teixidó
-
Affiliation Molecular Pathology Group, Vall d’Hebron Research Institute, Universidad Autonoma of Barcelona, Barcelona, Spain
- Rosó Marés
-
Affiliation Molecular Pathology Group, Vall d’Hebron Research Institute, Universidad Autonoma of Barcelona, Barcelona, Spain
- Miguel Aracil
-
Affiliation Pharmamar, Madrid, Spain
- Santiago Ramón y Cajal
-
Affiliation Pathology Department, Vall d’Hebron University Hospital, Universidad Autonoma of Barcelona, Barcelona, Spain
- Javier Hernández-Losa
-
* E-mail: jahernan@vhebron.net
Affiliation Pathology Department, Vall d’Hebron University Hospital, Universidad Autonoma of Barcelona, Barcelona, Spain
Competing Interests
Miguel Aracil is an employee for Pharmamar Company, which developed Elisidepsin. There are no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CT SRC JHL. Performed the experiments: CT RM. Analyzed the data: CT JHL. Contributed reagents/materials/analysis tools: CT RM MA SRC JHL. Wrote the paper: CT JHL.